Bone Biologics Corporation (BBLG) Investor Relations Documents
Bone Biologics Corporation (BBLG) investor relations documents from the company's IR site: 2 presentations, 16 press releases; latest deck 2026-08-18. Read in-app with summaries. First-party data.
Investor Presentation — Bone Biologics (BBLG) presents NELL-1, a regenerative medicine for bone, targeting the $3B spine fusion market with a clear regulatory path and strong IP.
Investor relations documents — source: company IR site| Published | Type | Document |
|---|
| 2026-08-18 | Presentation | Investor Presentation |
| 2026-08-12 | Press release | Bone Biologics Achieves 32-Month Validated Shelf Life for rhNELL-1 |
| 2026-07-23 | Press release | Bone Biologics Issues Mid-Year Shareholder Update Highlighting Progress Across 2026 Priorities |
| 2026-06-23 | Presentation | Investor Presentation |
| 2026-05-19 | Press release | Bone Biologics Achieves 29-Month Validated Shelf Life for rhNELL-1 |
| 2026-01-08 | Press release | Read More > |
| 2025-12-23 | Press release | Read More > |
| 2025-09-03 | Press release | Read More > |
| 2025-06-30 | Press release | Read More > |
| 2025-06-27 | Press release | Read More > |
| 2024-10-21 | Press release | Read More > |
| 2024-09-09 | Press release | Read More > |
| 2024-08-02 | Press release | Read More > |
| Press release | BURLINGTON, Mass. (September 3, 2025) (more…) |
| Press release | BURLINGTON, Mass. (June 26, 2025) — Bone Biologics Corporation (“Bone Biologics” or the “Company”) (more…) |
| Press release | BURLINGTON, Mass., Dec. 23, 2025 (GLOBE NEWSWIRE) (more…) |
| Press release | BURLINGTON, Mass. (September 4, 2025) – (more…) |
| Press release | BURLINGTON, Mass., Jan. 08, 2026 (GLOBE NEWSWIRE) (more…) |
BBLG overview · BBLG earnings · BBLG financials · BBLG KPIs · BBLG ownership · BBLG peers · BBLG filings
Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.